Stabilization of eye drops containing autologous serum and recombinant human epidermal growth factor for dry eye syndrome
Human epidermal growth factor (hEGF) and autologous serum are considered safer and more effective in treating dry eye syndrome. However, suitable formulas and preparation methods are needed to obtain eye drop containing autologous serum and hEGF, which are stable during storage and use. Therefore, t...
Saved in:
Main Authors: | Sriwidodo Sriwidodo (Author), Insan Sunan Kurniawan Syah (Author), Iman Permana Maksum (Author), Toto Subroto (Author), Ulvi Zasvia (Author), Abd Kakhar Umar (Author) |
---|---|
Format: | Book |
Published: |
Wolters Kluwer Medknow Publications,
2020-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Optimization of secreted recombinant human epidermal growth factor production using pectate lyase B from Escherichia coli BL21(DE3) by central composite design and its production in high cell density culture
by: Sriwidodo Sriwidodo, et al.
Published: (2019) -
Activity and Effectiveness of Recombinant hEGF Excreted by Escherichia coli BL21 on Wound Healing in Induced Diabetic Mice
by: Sriwidodo S, et al.
Published: (2020) -
Complexed Polymer Film-Forming Spray: An Optimal Delivery System for Secretome of Mesenchymal Stem Cell as Diabetic Wound Dressing?
by: Abd. Kakhar Umar, et al.
Published: (2022) -
In Vitro Inhibition of Evaporation with Perfluorohexyloctane, an Eye Drop for Dry Eye Disease
by: Jason Vittitow, Ph.D, et al.
Published: (2023) -
Development of Lutein-Containing Eye Drops for the Treatment of Dry Eye Syndrome
by: Yi-Zhou Chen, et al.
Published: (2021)